UniProt ID | DAB2_RAT | |
---|---|---|
UniProt AC | O88797 | |
Protein Name | Disabled homolog 2 | |
Gene Name | Dab2 | |
Organism | Rattus norvegicus (Rat). | |
Sequence Length | 768 | |
Subcellular Localization | Cytoplasm. Cytoplasmic vesicle, clathrin-coated vesicle membrane. Membrane, clathrin-coated pit. Colocalizes with large insert-containing isoforms of MYO6 at clathrin-coated pits/vesicles. During mitosis is progressively displaced from the membrane a | |
Protein Description | Adapter protein that functions as clathrin-associated sorting protein (CLASP) required for clathrin-mediated endocytosis of selected cargo proteins. Can bind and assemble clathrin, and binds simultaneously to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) and cargos containing non-phosphorylated NPXY internalization motifs, such as the LDL receptor, to recruit them to clathrin-coated pits. Can function in clathrin-mediated endocytosis independently of the AP-2 complex. Involved in endocytosis of integrin beta-1; this function seems to redundant with the AP-2 complex and seems to require DAB2 binding to endocytosis accessory EH domain-containing proteins such as EPS15, EPS15L1 and ITSN1. Involved in endocytosis of cystic fibrosis transmembrane conductance regulator/CFTR. Involved in endocytosis of megalin/LRP2 lipoprotein receptor during embryonal development. Required for recycling of the TGF-beta receptor. Involved in CFTR trafficking to the late endosome. Involved in several receptor-mediated signaling pathways. Involved in TGF-beta receptor signaling and facilitates phosphorylation of the signal transducer SMAD2. Mediates TFG-beta-stimulated JNK activation. May inhibit the canoniocal Wnt/beta-catenin signaling pathway by stabilizing the beta-catenin destruction complex through a competing association with axin preventing its dephosphorylation through protein phosphatase 1 (PP1). Sequesters LRP6 towards clathrin-mediated endocytosis, leading to inhibition of Wnt/beta-catenin signaling. May activate non-canonical Wnt signaling. In cell surface growth factor/Ras signaling pathways proposed to inhibit ERK activation by interrupting the binding of GRB2 to SOS1 and to inhibit SRC by preventing its activating phosphorylation at 'Tyr-419'. Proposed to be involved in modulation of androgen receptor (AR) signaling mediated by SRC activation; seems to compete with AR for interaction with SRC. Plays a role in the CSF-1 signal transduction pathway. Plays a role in cellular differentiation. Involved in cell positioning and formation of visceral endoderm (VE) during embryogenesis and proposed to be required in the VE to respond to Nodal signaling coming from the epiblast. Required for the epithelial to mesenchymal transition, a process necessary for proper embryonic development. May be involved in myeloid cell differentiation and can induce macrophage adhesion and spreading. May act as a tumor suppressor.. | |
Protein Sequence | MSNEVETSTTNGQPDQQAAPKAPSKKEKKKGSEKTDEYLLARFKGDGVKYKAKLIGIDDVPDARGDKMSQDSMMKLKGMAAAGRSQGQHKQRIWVNISLSGIKIIDEKTGVIEHEHPVNKISFIARDVTDNRAFGYVCGGEGQHQFFAIKTGQQAEPLVVDLKDLFQVIYNVKKKEEEKKKVEEANKAEENGSEALMTLDDQANKLKLGVDQMDLFGDMSTPPDLNNPTESRDILLVDLNSEIDTNQNSLRENPFLTNGVTSCSLPRPKPQASFLPESAFSANLNFFPTPNPDPFRDDPFAQPDQSAPSSFHSLTSADQKKANPGSLSTPQSKGPLNGDTDYFGQQFDQISNRTGKQEAQGGPWPYPSSQTQQAVRTQNGVSEKEQNGFHIKSSPNPFVGSPPKGLSVPNGVKQDLESSVQSSAHDSIAIIPPPQSTKPGRGRRTAKSSANDLLASDIFASEPPGQMSPTGQPAVPQANFMDLFKTSAPAPMGSGPLVGLGTVPVTPPQAGPWTPVVFTPSTTVVPGAIISGQPSGFGQPLVFGTTPAVQVWNQPSSFATAASPPPPAVWCPTTSVAPNTWSSTSPLGNPFQSSNIFPPSTISTQSFPQPMMSSVLVTPPQPPPRNGPLKDTLSDAFTGLDPLGDKEVKEVKEMFKDFQLRQPPLVPSRKGETPSSGTSSAFSSYFNNKVGIPQEHVDHDDFDANQLLNKINEPPKPAPRQGVLSGTKSADNSLENPFSKGFSSTNPSVVSQPASSDAHRSPFGNPFA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSNEVETST ------CCCCCCCCC | 41.52 | - | |
2 | Phosphorylation | ------MSNEVETST ------CCCCCCCCC | 41.52 | 22673903 | |
24 | Phosphorylation | QAAPKAPSKKEKKKG CCCCCCCCHHHHCCC | 62.31 | 11812785 | |
32 | Phosphorylation | KKEKKKGSEKTDEYL HHHHCCCCCCCCHHH | 44.81 | 25575281 | |
35 | Phosphorylation | KKKGSEKTDEYLLAR HCCCCCCCCHHHHHH | 29.97 | 25575281 | |
44 | Acetylation | EYLLARFKGDGVKYK HHHHHHHCCCCCEEE | 51.00 | 22902405 | |
108 | Acetylation | GIKIIDEKTGVIEHE CEEEEECCCCCEECC | 47.00 | 22902405 | |
170 | Phosphorylation | KDLFQVIYNVKKKEE HHHHHHHHHCCCHHH | 18.29 | - | |
193 | Phosphorylation | NKAEENGSEALMTLD HHHHHHHCHHCCCHH | 31.14 | 22673903 | |
221 | Phosphorylation | DLFGDMSTPPDLNNP HHCCCCCCCCCCCCC | 32.00 | 25532521 | |
326 | Phosphorylation | QKKANPGSLSTPQSK HHHCCCCCCCCCCCC | 22.02 | 25575281 | |
328 | Phosphorylation | KANPGSLSTPQSKGP HCCCCCCCCCCCCCC | 39.47 | 25532521 | |
329 | Phosphorylation | ANPGSLSTPQSKGPL CCCCCCCCCCCCCCC | 30.55 | 30181290 | |
332 | Phosphorylation | GSLSTPQSKGPLNGD CCCCCCCCCCCCCCC | 40.56 | 30181290 | |
393 | Phosphorylation | QNGFHIKSSPNPFVG HCCEECCCCCCCCCC | 50.88 | 25575281 | |
394 | Phosphorylation | NGFHIKSSPNPFVGS CCEECCCCCCCCCCC | 24.56 | 25532521 | |
401 | Phosphorylation | SPNPFVGSPPKGLSV CCCCCCCCCCCCCCC | 32.50 | 27097102 | |
468 | Phosphorylation | SEPPGQMSPTGQPAV CCCCCCCCCCCCCCC | 16.06 | 22668510 | |
618 | Phosphorylation | MMSSVLVTPPQPPPR CEEEEEECCCCCCCC | 25.70 | - | |
652 | Acetylation | DKEVKEVKEMFKDFQ CHHHHHHHHHHHHCC | 44.55 | 22902405 | |
673 | Phosphorylation | VPSRKGETPSSGTSS CCCCCCCCCCCCCHH | 36.82 | - | |
675 | Phosphorylation | SRKGETPSSGTSSAF CCCCCCCCCCCHHHH | 49.14 | - | |
725 | Phosphorylation | APRQGVLSGTKSADN CCCCCCCCCCCCCCC | 41.85 | 25575281 | |
727 | Phosphorylation | RQGVLSGTKSADNSL CCCCCCCCCCCCCCC | 20.60 | 25575281 | |
729 | Phosphorylation | GVLSGTKSADNSLEN CCCCCCCCCCCCCCC | 40.47 | 29779826 | |
733 | Phosphorylation | GTKSADNSLENPFSK CCCCCCCCCCCCCCC | 37.29 | 25575281 | |
739 | Phosphorylation | NSLENPFSKGFSSTN CCCCCCCCCCCCCCC | 32.88 | 25575281 | |
751 | Phosphorylation | STNPSVVSQPASSDA CCCCCHHCCCCCCCC | 28.43 | 23984901 | |
755 | Phosphorylation | SVVSQPASSDAHRSP CHHCCCCCCCCCCCC | 35.12 | 23984901 | |
756 | Phosphorylation | VVSQPASSDAHRSPF HHCCCCCCCCCCCCC | 40.71 | 23984901 | |
761 | Phosphorylation | ASSDAHRSPFGNPFA CCCCCCCCCCCCCCC | 18.08 | 23984901 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
24 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DAB2_RAT !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DAB2_RAT !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of DAB2_RAT !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...